Peg L-Aspatero 3750 IU Injection
$318,28
$232,32
Peg L-Aspatero 3750 IU Injection is an effective treatment option for various types of blood cancers, including acute lymphoblastic leukemia and Hodgkin's lymphoma. This medication works by inhibiting the growth of cancer cells, helping to manage and reduce the progression of these diseases. Often utilized in conjunction with other chemotherapy agents, Peg L-Aspatero enhances the overall efficacy of cancer treatment regimens. Patients should be aware of potential side effects, such as allergic reactions and liver function alterations, and should communicate any unusual symptoms to their healthcare provider promptly. It is crucial to adhere to dosing guidelines to optimize therapeutic outcomes while minimizing risks. Regular monitoring of blood counts and liver enzymes is recommended during treatment. With its targeted action, Peg L-Aspatero represents a vital component in the fight against specific hematological malignancies, offering hope to patients and their families. Always consult a healthcare professional for personalized advice and information regarding your treatment plan.
數量
Active Pharmaceutical Ingredient
Uses
• Peg l aspatero 3750 iu injection is utilized in the treatment of acute lymphocytic leukaemia, a type of blood cancer that primarily affects children and young adults. This medication works by enhancing the body's ability to fight cancer cells. By targeting specific pathways involved in the growth of leukaemia cells, Peg l aspatero 3750 iu injection helps to improve treatment outcomes. It is often administered as part of a comprehensive chemotherapy regimen.
• In addition to acute lymphocytic leukaemia, Peg l aspatero 3750 iu injection is also indicated for the treatment of Non-Hodgkin's lymphoma (NHL). NHL encompasses a diverse group of blood cancers that arise from lymphocytes, a type of white blood cell. This injection aids in managing the disease by disrupting the proliferation of malignant cells. As a result, Peg l aspatero 3750 iu injection can help to achieve remission in patients with NHL.
• Peg l aspatero 3750 iu injection is often used in combination with other therapies to enhance overall efficacy against blood cancers. Its mechanism of action allows it to be effective in various treatment protocols, providing oncologists with a valuable tool in their arsenal. Patients receiving Peg l aspatero 3750 iu injection may experience improved responses to their cancer treatment. This makes it an essential option for those diagnosed with specific hematologic malignancies.
• The use of Peg l aspatero 3750 iu injection is critical in the management of certain aggressive forms of blood cancer. It is typically administered in specialized healthcare settings where patients can be closely monitored. The injection plays a significant role in the treatment landscape for blood cancers, offering hope to patients and their families. By utilizing Peg l aspatero 3750 iu injection, healthcare providers aim to improve survival rates and quality of life for those affected.
Benefits
Blood cancer (acute lymphocytic leukemia): Blood cancer, known as leukemia, is a malignancy that affects the blood-forming tissues and impairs the body's immune response to infection. Administration of Peg L-Aspatero 3750 IU Injection inhibits the proliferation of cancer cells and effectively eradicates them. This Peg L-Aspatero 3750 IU Injection has significant potency and toxicity, so a thorough discussion with your doctor regarding its potential risks and benefits is necessary. It is important to avoid alcohol during this treatment and to ensure adequate hydration by drinking plenty of water. Non-Hodgkin's lymphoma (NHL): Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is a part of the body's germ-combating immune system. Administration of Peg L-Aspatero 3750 IU Injection inhibits the proliferation of cancer cells and effectively eradicates them. This medication has significant potency and toxicity, so a thorough discussion with your doctor regarding its potential risks and benefits is necessary. It is important to avoid alcohol during this treatment and to ensure adequate hydration by drinking plenty of water.
Side Effects
Like all medicines, Peg L-Aspatero 3750 IU Injection may cause side effects that do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Nausea
• Vomiting
• Weakness
• Loss of appetite
• Diarrhoea
• Epigastric pain
• Swelling over hands/ feet and ankles
• Injection site reaction ( like pain, redness, swelling)
• Irritability
Common Side Effects
• Drowsiness
• Acute Pancreatitis ( Pain in abdomen, unable to eat, swollen and tender abdomen, Rapid pulse)
• Headache
• Tiredness
• Irritability
• Stomach cramps
• Weight loss
How To Use
Peg L-Aspatero 3750 IU Injection is available in liquid form (injectable) for IM and IV use, which should be administered by a healthcare professional under medical supervision. The dosage and frequency of administration will be determined by your physician based on your medical condition and many other factors. Peg L-Aspatero 3750 IU Injection should not be self-administered.
Safety Advice
• Alcohol: Drinking alcohol while taking Peg L-Aspatero 3750 IU is generally not recommended. It may increase the risk of liver damage and it is best to avoid alcohol or to limit the amount of alcohol you drink while you are taking this medicine.
• Kidney: For patients with kidney impairment, dose adjustment is not recommended. Peg L-Aspatero 3750 IU Injection has not been studied in patients with severe renal impairment or in patients who are undergoing peritoneal dialysis or haemodialysis.
• Breastfeeding: Breastfeeding while taking Peg L-Aspatero 3750 IU Injection is not recommended as it may be harmful to the baby. The constituents of Peg L-Aspatero 3750 IU can potentially pass into breast milk and pose a risk to the baby. If you are currently breastfeeding and using Peg L-Aspatero Injection, it is important to discuss the potential benefits and risks of continuing to breastfeed with your doctor. Your doctor will be able to advise you on how to ensure the optimum health of both you and your baby.
• Liver: For patients with mild liver disease, Peg L-Aspatero 3750 IU Injection is recommended. No dose adjustment is required in patients with mild liver impairment. However, Peg L-Aspatero 3750 IU is not recommended for use in patients with moderate or severe liver disease.
• Pregnancy: The use of Peg L-Aspatero 3750 IU Injection is not recommended in pregnant women as it may cause harm to the foetus if administered to a pregnant woman.
• Driving: It is uncommon for Peg L-Aspatero 3750 IU Injection to affect your driving skills.